Literature DB >> 6192336

Pyrazolopyrimidine metabolism in the pathogenic trypanosomatidae.

J J Marr, R L Berens.   

Abstract

Pyrazolopyrimidines are purine analogues. These compounds are metabolized by the pathogenic hemoflagellates and other members of the family Trypanosomatidae as though they were purines. This metabolic sequence does not exist in man or other mammals. In the hemoflagellates, the pyrazolopyrimidine base, of which allopurinol is the paradigm, undergoes ribosylphosphorylation to the ribonucleotide. This ribonucleotide may remain as such or be aminated to the amino analogue and further converted to the aminopyrazolopyrimidine ribonucleoside triphosphate. The latter is incorporated into RNA. This metabolic sequence has been demonstrated in the genera Leishmania and Trypanosoma.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6192336     DOI: 10.1016/0166-6851(83)90016-6

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  21 in total

1.  Point mutations in a nucleoside transporter gene from Leishmania donovani confer drug resistance and alter substrate selectivity.

Authors:  G Vasudevan; B Ullman; S M Landfear
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-15       Impact factor: 11.205

2.  Purification and properties of 3'-nucleotidase of Leishmania donovani.

Authors:  G O Gbenle; D M Dwyer
Journal:  Biochem J       Date:  1992-07-01       Impact factor: 3.857

3.  Hypoxanthine phosphoribosyltransferase from Trypanosoma cruzi as a target for structure-based inhibitor design: crystallization and inhibition studies with purine analogs.

Authors:  A E Eakin; A Guerra; P J Focia; J Torres-Martinez; S P Craig
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

4.  Uptake of the antitrypanosomal drug 5'-([(Z)-4-amino-2-butenyl]methylamino)-5'-deoxyadenosine (MDL 73811) by the purine transport system of Trypanosoma brucei brucei.

Authors:  T L Byers; P Casara; A J Bitonti
Journal:  Biochem J       Date:  1992-05-01       Impact factor: 3.857

5.  Antiviral screening identifies adenosine analogs targeting the endogenous dsRNA Leishmania RNA virus 1 (LRV1) pathogenicity factor.

Authors:  F Matthew Kuhlmann; John I Robinson; Gregory R Bluemling; Catherine Ronet; Nicolas Fasel; Stephen M Beverley
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-17       Impact factor: 11.205

6.  Biological action of inosine analogs in Leishmania and Trypanosoma spp.

Authors:  J J Marr; R L Berens; N K Cohn; D J Nelson; R S Klein
Journal:  Antimicrob Agents Chemother       Date:  1984-02       Impact factor: 5.191

7.  Purine-metabolizing enzymes in Babesia divergens.

Authors:  H F Hassan; R S Phillips; G H Coombs
Journal:  Parasitol Res       Date:  1987       Impact factor: 2.289

8.  Cloning of Leishmania nucleoside transporter genes by rescue of a transport-deficient mutant.

Authors:  G Vasudevan; N S Carter; M E Drew; S M Beverley; M A Sanchez; A Seyfang; B Ullman; S M Landfear
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

9.  Activity of purine analogs against Leishmania donovani in vivo.

Authors:  J D Berman; W L Hanson; J K Lovelace; V B Waits; J E Jackson; W L Chapman; R S Klein
Journal:  Antimicrob Agents Chemother       Date:  1987-01       Impact factor: 5.191

10.  Inosine analogs as chemotherapeutic agents for African trypanosomes: metabolism in trypanosomes and efficacy in tissue culture.

Authors:  W R Fish; J J Marr; R L Berens; D L Looker; D J Nelson; S W LaFon; A E Balber
Journal:  Antimicrob Agents Chemother       Date:  1985-01       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.